Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects

BioMedicine (Netherlands)

Volumn 2, Issue 4, 2012, Pages 130-136

  Jao, Chia Ling ^a   Huang, Shih Li ^b   Hsu, Kuo Chiang ^c  

^a TUNG FANG DESIGN UNIVERSITY   (Taiwan)

^b NATIONAL KAOHSIUNG UNIVERSITY OF HOSPITALITY AND TOURISM   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ACE inhibitory peptide; Antihypertensive effect; Bioavailability; Gastrointestinal digestion; Inhibition mode

Indexed keywords

ALANYLTRYPTOPHAN; ANGIOTENSIN I; ASPARAGINYLGLYCINE; ASPARAGINYLISOLEUCYLPROLYLPROLYLLEUCYLTHREONYLGLUTAMINYLTHREONYLPROLYLVALINE; ASPARAGINYLLEUCYLPROLINE; ASPARTYLLYSYLISOLEUCYLHISTIDINYLPROLYLPHENYLALANINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GASTROINTESTINAL ENZYME; INTESTINE ENZYME; ISOLEUCYLPHENYLALANYLLEUCINE; ISOLEUCYLTRYPTOPHAN; LEUCYLASPARAGINYLVALYLPROLYLGLYCYLGLUTAMYLISOLEUCYLVALYLGLUTAMIC ACID; LEUCYLGLYCYLPHENYLALANYLPROLYLTHREONYLTHREONYLLYSYLTHREONYLTYROSYLPHENYLALANYLPROPYLHISTIDINYLPHENYLALANINE; LEUCYLPHENYLALANINE; LYSYLVALYLARGINYLGLUTAMYLGLYCYLTHREONINE; LYSYLVALYLARGINYLGLUTAMYLGLYCYLTHREONYLTHREONYLTYROSINE; PEPTIDASE; PEPTIDE DERIVATIVE; PHENYLALANINETYROSINE; PHENYLALANYLLEUCINE; THREONYLLEUCYLTHREONYLASPARTYLTYROSINE; TRYPTOPHANYLALANINE; TRYPTOPHANYLLYSINE; TYROSYLASPARAGINE; TYROSYLLYSYLTYROSYLGLUTAMYLISOLEUCYLALANYLARGINYLARGININE; TYROSYLPROLYLISOLEUCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLISOLEUCYLGLUTAMYLLYSYLTYROSYLPROLINE; VALYLVALYLTYROSYLPROLYLTRYPTOPHANYLTHREONYLGLUTAMINYLARGINYLPHENYLALANINE; VALYLVALYLTYROSYLPROLYLTRYPTOPHYLTHREONINE;

ANTIHYPERTENSIVE ACTIVITY; COMPETITIVE INHIBITION; DRUG BIOAVAILABILITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE BRUSH BORDER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIMULATION; STRUCTURE ACTIVITY RELATION;

EID: 84871621268     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.06.005     Document Type: Review

References (50)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
2. Brunner H.R., Laragh J.H., Baer L., Newton M.A., Goodwin F.T., Krakoff L.R., et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972, 286:441-449.
3. Ondetti M.A., Rubin B., Cushman D.W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 1977, 4288:441-444.
4. Patchett A.A., Harris E., Tristram E.W., Wyvratt M.J., Wu M.T., Taub D., et al. A new class of angiotensin-converting enzyme inhibitors. Nature 1980, 298:280-283.
5. Oshima G., Shimabukuro H., Nagasawa K. Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase. Biochim Biophys Acta 1979, 566:128-137.
6. Mullally M.M., Meisel H., FitzGerald R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-lactoglobulin. FEBS Lett 1997, 402:99-101.
7. Yano S., Suzuki K., Funatsu G. Isolation from alpha-zein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci Biotechnol Biochem 1996, 60:661-663.
8. Megías C., del Mar Yust M., Pedroche J., Lquari H., Girón-Calle J., Alaiz M., et al. Purification of an ACE inhibitory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates. J Agric Food Chem 2004, 52:1928-1932.
9. Yoshikawa M., Fujita H., Matoba N., Takenaka Y., Yamamoto T., Yamauchi R., et al. Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 2000, 12:143-146.
10. Matsui T., Li C.H., Osajima Y. Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Pept Sci 1999, 5:289-297.
11. Je J.Y., Park J.Y., Jung W.K., Park P.J., Kim S.K. Isolation of angiotensin I converting enzyme (ACE) inhibitor from fermented oyster sauce, Crassostrea gigas. Food Chem 2005, 90:809-814.
12. Lee S.H., Qian Z.J., Kim S.K. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chem 2010, 118:96-102.
13. Zhao Y., Li B., Dong S., Liu Z., Zhao X., Wang J., et al. A novel ACE inhibitory peptide isolated from Acaudina molpadioidea hydrolysate. Peptides 2009, 30:1028-1033.
14. Qian Z.J., Je J.Y., Kim S.K. Antihypertensive effect of angiotensin I converting enzyme-inhibitory peptide from hydrolysates of Bigeye tuna dark muscle, Thunnus obesus. J Agric Food Chem 2007, 55:8398-8403.
15. Suetsuna K., Nakano T. Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem 2000, 11:450-454.
16. Sato M., Hosokawa T., Yamaguchi T., Nakano T., Muramoto K., Kahara T., et al. Angiotensin I-converting enzyme inhibitory peptides derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J Agric Food Chem 2002, 50:6245-6252.
17. Nakagomi K., Fujimura A., Ebisu H., Sakai T., Sadakane Y., Fujii N., et al. Acein-1, a novel angiotensin-I-converting enzyme inhibitory peptide isolated from tryptic hydrolysate of human plasma. FEBS Lett 1998, 438:255-257.
18. Samaranayaka A.G.P., Kitts D.D., Li-Chan E.C.Y. Antioxidative and angiotensin-I-converting enzyme inhibitory potential of a Pacific hake (Merluccius productus) fish protein hydrolysate subjected to simulated gastrointestinal digestion and Caco-2 cell permeation. J Agric Food Chem 2010, 58:1535-1542.
19. Kuba M., Tanaka K., Tawata S., Takeda Y., Yasuda M. Angiotensin I-converting enzyme inhibitory peptides isolated from tofuyo fermented soybean food. Biosci Biotechnol Biochem 2003, 67:1278-1283.
20. Wang J.P., Hu J., Cui J., Bai X., Du Y., Miyaguchi Y., et al. Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats. Food Chem 2008, 111:302-308.
21. Meisel H. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers 1997, 43:119-128.
22. Ferreira S.H., Bartelt D.C., Greene L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 1970, 9:2583-2593.
23. Hong F., Ming L., Yi S., Zhanxia L., Yongquan W., Chi L. The antihypertensive effect of peptides: a novel alternative to drugs?. Peptides 2008, 29:1062-1071.
24. Wu J., Ding X. Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Res Int 2002, 35:367-375.
25. Tsai J.S., Chen J.L., Pan B.S. ACE-inhibitory peptides identified from the muscle protein hydrolysate of hard clam (Meretrix lusoria). Process Biochem 2008, 43:743-747.
26. Yu Y., Hu J., Miyaguchi Y., Bai X., Du Y., Lin B. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides 2006, 27:2950-2956.
27. Gobbetti M., Ferranti P., Smacchi E., Goffredi F., Addeo F. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl Environ Microbiol 2000, 66:3898-3904.
28. Ono S., Hosokawa M., Miyashita K., Takahashi K. Inhibition properties of dipeptides from salmon muscle hydrolysate on angiotensin I-converting enzyme. Int J Food Sci Technol 2006, 41:383-386.
29. Li G.H., Le G.W., Shi Y.H., Shrestha S. Angiotensin I - converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr Res 2004, 24:469-486.
30. Ondetti M.A., Cushman D.W. Enzymes of the renin-angiotensin system and their inhibitors. Annu Rev Biochem 1982, 51:283-308.
31. Choi H.S., Cho H.Y., Yang H.C., Ra K.S., Suh H.J. Angiotensin I-converting enzyme inhibitor from Grifola frondosa. Food Res Int 2001, 34:177-182.
32. Lee J.K., Hong S., Jeon J.K., Kim S.K., Byun H.G. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis. Bioresour Technol 2009, 100:5255-5259.
33. Si D., Wang Y., Zhou Y.H., Guo Y., Wang J., Zhou H., et al. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 2009, 37:629-634.
34. Lee N.Y., Cheng J.T., Enomoto T., Nakano Y. One peptide derived from hen ovotransferrin as pro-drug to inhibit angiotensin converting enzyme. J Food Drug Anal 2006, 14:31-35.
35. Shiozaki K., Shiozaki M., Masuda J., Yamauchi A., Ohwada S., Nakano T., et al. Identification of oyster-derived hypotensive peptide acting as angiotensin-I-converting enzyme inhibitor. Fish Sci 2010, 76:865-872.
36. Sheih I.C., Fang T.J., Wu T.K. Isolation and characterization of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste. Food Chem 2009, 115:279-284.
37. Jung W.K., Mendis E., Je J.Y., Park P.J., Son B.W., Kim H.C., et al. Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats. Food Chem 2006, 94:26-32.
38. Ni H., Li L., Liu G., Hu S.Q. Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae). PLoS One 2012, 7:e37077.
39. Fujita H., Yokoyama K., Yoshikawa M. Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 2000, 65:564-569.
40. Li G.H., Qu M.R., Wan J.Z., You J.M. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats. Asia Pac J Clin Nutr 2007, 16(Suppl. 1):275-280.
41. Ren Y., Wan D.-G., Lu X.-M., Chen L., Zhang T., Guo J.-L. Isolation and characterization of angiotensin I-converting enzyme inhibitor peptides derived from porcine hemoglobin. Sci Res Essays 2011, 6:6262-6269.
42. Ohsawa K., Satsu H., Ohki K., Enjoh M., Takano T., Shimizu M. Producibility and digestibility of antihypertensive β-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J Agric Food Chem 2008, 56:854-858.
43. Miguel M., Aleixandre M.A., Ramos M., López-Fandiño R. Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. J Agric Food Chem 2006, 54:726-731.
44. Maeno M., Yamamoto N., Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1996, 79:1316-1321.
45. Vanhoof G., Goossens F., De Meester I., Hendriks D., Scharpé S. Proline motifs in peptides and their biological processing. FASEB J 1995, 9:736-744.
46. FitzGerald R.J., Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000, 84(Suppl. 1):S33-S37.
47. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppälä A., Korhonen H., Korpela R., et al. α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 2002, 71:1245-1253.
48. Kouno K., Hirano S., Kuboki H., Kasai M., Hatae K. Effects of dried bonito (katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action. Biosci Biotechnol Biochem 2005, 69:911-915.
49. Maes W., Van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers J.M., Schrezenmeir J., et al. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept 2004, 118:105-109.
50. Touyz R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004, 44:248-252.